Chiu and his team will examine your areas of concern, discuss how much weight you have lost, review your GLP-1 medication history, and discuss about whether your concerns are mostly functional, cosmetic, or both
It has also been noted that fat is preferentially lost from the trunk compared with the limbs in patients with IIH undergoing therapeutic weight loss resulting in significant reduction of ICP
we help you understand your body, take control of your health, and build long-term resilience
Given the relatively smaller reduction in body weight (9.4%) in the SELECT trial compared to previous RCTs: 14.9% in STEP1 (BMI 37.86.7 kg/m 2 ) [16] and 13.2% STEP6 (BMI 31.9 kg/m 2 ) [49], pleiotropic effects of semaglutide may contribute to the overall CV risk reduction [25,37]
Elevate your trial success rate with the cutting-edge insights from Clival database
Maybe you had a telehealth visit, answered questions about your health history, and a licensed provider determined that GLP-1 therapy fits your treatment plan